Perspective
Our work in Perspective
-
NEJM: Competing Visions for the Future of Health Policy
Beyond Covid-19, two other health policy issues are poised to feature prominently in the 2020 U.S. elections: what role government should play in ensuring broad health insurance coverage, and how to cope with the lack of competition in many health care provider markets.
Categorized in -
Declaring the Vape Industry Illegal Will Only Drive It Underground
Declaring a multi-billion dollar industry illegal will only drive it underground. It will also make the health effects of vaping even more difficult to ascertain.
Categorized in -
Sharing Drug Rebates With Medicare Part D Patients: Why And How
The percentage of total Medicare Part D drug spending offset by rebates on branded drugs increased from 11% in 2010 to 25% in 2018.
Categorized in -
The COVID-19 Vaccine Model Needs to Prioritize ‘Superspreaders.’ Here is Why.
After taking care of essential workers, vaccinations should be given to the biggest transmitters of the virus – mostly the young – and only then to the most vulnerable.
Categorized in -
How To Boost Health Insurance Enrollment: Three Practical Steps That Merit Bipartisan Support
The authors explain how gaps in eligibility for federal assistance programs, perceptions of affordability, and administrative complexity create barriers that prevent millions of Americans from obtaining affordable coverage.
Categorized in -
Overcoming Barriers to Success in Alzheimer’s Disease Clinical Trials
Even modest delays in the progression of Alzheimer’s disease could dramatically alter the current trajectory and generate large health benefits.
Categorized in -
How to Ensure COVID-19 Doesn’t Delay Value-Based Care
The authors suggest supporting the adoption and existence of ACOs and preventing the loss of value-based opportunities via private equity or large hospital network acquisitions.
Categorized in -
Yes, We Need a Vaccine to Control COVID-19. But We Need New Treatments, Too.
New treatments for Covid-19 are needed before a vaccine is ready and as the essential backstop to manage it afterward, since vaccines aren’t perfect.
Categorized in -
The Need To More Effectively Regulate END Markets: A Primary Public Health Lesson of the US Vaping Associated Lung Injury Outbreak
The designation of END products as “tobacco products” rather than “medical products” in August 2016 meant manufacturers did not have to meet pharmaceutical safety standards; instead, minimal product safety regulations were imposed.
Categorized in -
California Must Quickly Implement Policies for Tracking and Controlling Health Care Costs and Price Increases
To protect Californians from rising health care costs, the state needs to strengthen price transparency and price competition, according to Melnick.
Categorized in